ONCT - Oncternal Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ONCT is currently covered by 4 analysts with an average price target of $15.26. This is a potential upside of $14.73 (2779.25%) from yesterday's end of day stock price of $0.53.

Oncternal Therapeutics's activity chart (see below) currently has 2 price targets and 17 ratings on display. The stock rating distribution of ONCT is 61.54% BUY and 38.46% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.86% with an average time for these price targets to be met of 40.6 days.

Highest price target for ONCT is $18, Lowest price target is $18, average price target is $15.33.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 12-Aug-2024. First documented stock forecast 10-Aug-2020.

Best performing analysts who are covering ONCT - Oncternal Therapeutics:

Hartaj Singh Li Watsek Raghuram Selvaraju Naureen Quibria Kemp Dolliver

Currently out of the existing stock ratings of ONCT, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$18

$16.86 (1478.95%)

$19

9 months 18 days ago
(12-Aug-2024)

1/7 (14.29%)

$13.83 (331.65%)

190

Buy

$2

$-5.6 (-73.68%)

1 years 5 months 26 days ago
(04-Dec-2023)

0/1 (0%)

$-5 (-71.43%)

Hold

$26

$24.86 (2180.70%)

1 years 8 months 23 days ago
(07-Sep-2023)

0/2 (0%)

$20 (333.33%)

Hold

$70

2 years 1 months 26 days ago
(04-Apr-2023)

0/1 (0%)

$50 (250.00%)

Hold

$9

2 years 1 months 26 days ago
(04-Apr-2023)

1/1 (100%)

$-5.2 (-36.62%)

13

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCT (Oncternal Therapeutics) average time for price targets to be met?

On average it took 40.6 days on average for the stock forecasts to be realized with a an average price target met ratio 22.86

Which analyst has the current highest performing score on ONCT (Oncternal Therapeutics) with a proven track record?

HARTAJ SINGH

Which analyst has the current lower performing score on ONCT (Oncternal Therapeutics) with a proven track record?

KEMP DOLLIVER

Which analyst has the most public recommendations on ONCT (Oncternal Therapeutics)?

Hartaj Singh works at OPPENHEIMER and has 5 price targets and 4 ratings on ONCT

Which analyst is the currently most bullish on ONCT (Oncternal Therapeutics)?

Li Watsek with highest potential upside - $24.86

Which analyst is the currently most reserved on ONCT (Oncternal Therapeutics)?

Kemp Dolliver with lowest potential downside - -$5.6

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?